RAC 5.59% $1.70 race oncology ltd

Ann: Updated Strategy and Investor Presentation, page-395

  1. 34 Posts.
    @Davisite

    For the all comers trial will we be taking any cancer type that comes along and is applicable or will we try and get patients with cancers that are sensitive to our drug?

    I was just thinking if we get a case of luck and that all the cancers we treat do not respond well, but also could go the other way.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.